Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 26,593 |
|
|||||
| News | - | ||||||
| Day High | 2.656 | Low High |
|||||
| Day Low | 2.4517 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cocrystal Pharma Inc | COCP | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0854 | -3.31% | 2.4947 | 10:49:48 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.59 | 2.4517 | 2.656 | 2.5801 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 149 | 26,593 | US$ 2.57 | US$ 68,319 | - | 1.325 - 3.285 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 10:49:48 | 120 | US$ 2.4947 | USD |
Cocrystal Pharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 25.23M | 10.17M | - | 2.6M | -17.98M | -1.77 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cocrystal Pharma News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/13/2024 | 07:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/13/2024 | 07:00 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 5/13/2024 | 07:00 | GlobeNewswire Inc. | Cocrystal Pharma Reports First Quarter 2024 Financial.. |
| 5/07/2024 | 15:30 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 5/01/2024 | 07:00 | GlobeNewswire Inc. | Enrollment Completed in Phase 2a Study with Cocrystal.. |
| 3/28/2024 | 07:00 | GlobeNewswire Inc. | Cocrystal Pharma Reports 2023 Financial Results and Provides.. |
| 3/19/2024 | 07:00 | GlobeNewswire Inc. | Cocrystal Pharma Receives Pre-IND Responses from the FDA on.. |
| 3/01/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/08/2024 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/04/2024 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/04/2024 | 07:00 | GlobeNewswire Inc. | Cocrystal Pharma Provides an Update on the Clinical.. |
| 1/02/2024 | 08:53 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical COCP Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.32 | 2.74 | 2.175 | 2.48 | 44,290 | 0.1747 | 7.53% |
| 1 Month | 1.72 | 2.74 | 1.70 | 2.21 | 47,547 | 0.7747 | 45.04% |
| 3 Months | 1.50 | 2.74 | 1.35 | 1.93 | 27,118 | 0.9947 | 66.31% |
| 6 Months | 1.80 | 2.74 | 1.325 | 1.82 | 19,601 | 0.6947 | 38.59% |
| 1 Year | 2.47 | 3.285 | 1.325 | 2.13 | 23,377 | 0.0247 | 1.00% |
| 3 Years | 14.52 | 17.88 | 1.325 | 12.39 | 595,821 | -12.03 | -82.82% |
| 5 Years | 26.52 | 49.20 | 1.325 | 18.88 | 2,025,037 | -24.03 | -90.59% |
Cocrystal Pharma Description
| Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). |
